Results 21 to 30 of about 13,265 (250)
Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus. [PDF]
PLoS ONE, 2008 Barrett's esophagus is a premalignant condition whereby the normal stratified squamous esophageal epithelium undergoes a transdifferentiation program resulting in a simple columnar epithelium reminiscent of the small intestine.
Douglas B Stairs +7 more
doaj +1 more source
The Korean Journal of Helicobacter and Upper Gastrointestinal Research, 2022 Barrett’s esophagus (BE) is caused by metaplasia of squamous epithelium into columnar epithelium, mainly in the lower esophagus. Updates have been made in the etiology, diagnosis and treatment of BE since its first report as an ulcerative lesion in the ...
Yong Kang Lee
doaj +1 more source
LOW PREVALENCE OF BARRETT’S ESOPHAGUS IN A RISK AREA FOR ESOPHAGEAL CANCER IN SOUTH OF BRAZIL
Arquivos de Gastroenterologia, 2017 BACKGROUND: Barrett’s esophagus a complication of gastroesophageal reflux disease (GERD) is a precursor of esophageal adenocarcinoma. The incidence of esophageal adenocarcinoma has been increasing in most Western countries.
Diego Michelon DE CARLI +2 more
doaj +1 more source
Barrett's esophagus in childhood [PDF]
Gastroenterology, 1984 This study describes the clinical, radiologic, esophageal function test, endoscopic, and histologic findings of Barrett's esophagus in 11 children aged 6-14 yr. All had long-standing symptoms of gastroesophageal reflux, which had begun in the first year of life in 10 of the 11.
Wilfred M. Weinstein +2 more
openaire +3 more sources
Long-term results of the mucosal ablation of Barrett's esophagus: efficacy and recurrence
Endoscopy International Open, 2015 Background and study aims: It has been postulated that the endoscopic ablation of Barrett’s esophagus can lead to complete eradication of the disease.
Shreyas Saligram +12 more
doaj +1 more source
Case Reports in Gastrointestinal Medicine, 2016 Background. Barrett’s esophagus is associated with an increased risk of adenocarcinoma. Dysplasia in Barrett’s esophagus is a precursor to adenocarcinoma. Rarely, dysplastic polypoid lesions are superimposed on Barrett’s esophagus. Most reported cases of
Megan Murphy +3 more
doaj +1 more source
Cellular and Molecular Gastroenterology and Hepatology, 2017 Barrett's esophagus is the metaplastic change of the squamous epithelium lining the distal esophagus into an intestinalized columnar epithelium that predisposes to esophageal adenocarcinoma development. The cell that gives rise to Barrett's esophagus has
David H. Wang MD,, PhD
doaj +1 more source
Barrett’s esophagus: novel strategies for screening and surveillance
Therapeutic Advances in Chronic Disease, 2019 Barrett’s esophagus is the precursor lesion for esophageal adenocarcinoma. Screening and surveillance of Barrett’s esophagus are undertaken with the goal of earlier detection and lowering the mortality from esophageal adenocarcinoma.
Vedha Sanghi, Prashanthi N. Thota
doaj +1 more source
BMC Gastroenterology, 2018 Background We aim to investigate factors that may contribute to failure of eradication of dysplastic Barrett’s Esophagus among patients undergoing radiofrequency ablation treatment.
Tyler Luckett +5 more
doaj +1 more source
Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma
Molecular Oncology, EarlyView.The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias +12 more
wiley +1 more source